Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)
Clinical trial NCT02071056 · COMPLETED
Trial details
- NCT number
- NCT02071056
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-11-25
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.